Navigation Links
Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
Date:4/2/2008

Peter J. McGuire, MB BCh, of Mount Sinai Medical Center, New York was honored as the 2008-2009 recipient of the Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2008 Annual Clinical Genetics Meeting in Phoenix, AZ.

The objective of the Genzyme/ACMGF Award is to support a national fellowship program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. This award grants $75,000 per year and will provide for the sponsorship of a trainees first year of fellowship following residency in a genetics fellowship on biochemical genetic diseases.

The Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics is especially important at this point in history as we work together to increase the genetics workforce and to advance education, research and standards of practice in medical genetics in the United States. said R. Rodney Howell, MD, FACMG, president of the ACMGF.


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1

Related biology news :

1. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
2. UM coral scientist Peter Glynn wins award for scholarly activity
3. 12 McGill researchers awarded Canada Research Chairs
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. ETH Zurich professor Ari Helenius awarded Benoist Prize
6. Nanobiosym awarded $2 million DTRA contract
7. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
8. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
9. $2.7 million awarded for metastatic colon cancer research
10. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
11. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: